2,2,3,3-TETRAMETHYL-4,7,10-TRIOXA-3-SILADODECAN-12-OL, 95.0%, 25g

2-(4-BROMO-2-CHLOROPHENYL)ETHANOL, 95.0%, 250mg

tert-Butyl 4-(6-nitropyridin-2-yl)piperazine-1-carboxylate, 97.0%, 250mg

4-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine, 95%, 250mg

7-Fluorobenzo[d]oxazol-2(3H)-one, 97%, 10g

4-Amino-2-naphthoic acid, 96%, 1g

LDN-22684>98.0%(HPLC)100mg

6-Fluoro-2-methyl-3-(methylthio)pyridine, 95+%, 1g

(E)-2-(4-Methoxystyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 10g

methyl 4-amino-2-(2-aminoethyl)butanoate dihydrochloride, 95.0%, 250mg

1,4-Dioxane, min. 99.5%, for synthesis, stabilized, 500 ml, glass packaging

2-(Bromomethyl)-6-fluoropyridine, 95.0%, 25g

(R)-1-Boc-4-Cbz-2-Methylpiperazine, 95.0%, 250mg